For a youthful, firmer you, ask for Sculptra®
Sculptra® activates the power of your skin by revitalizing collagen production.¹ With Sculptra®, you will renew skin thickness and firmness and correct shallow to deep wrinkles and folds.² Sculptra® gradually builds the foundations of the youthful, firmer you, day after day.³
Why Sculptra®?
Sculptra® activates the skin’s ability to produce collagen, restoring the skin’s structure and renewing its natural firmness.4 Collagen is a fibrous protein in the deeper layers of your skin and is key in making your skin look young and healthy. As you age, your body’s collagen production decreases. The loss of collagen will in time lead to loose and saggy skin and the formation of facial wrinkles and folds.5
Sculptra® is the original collagen stimulator that will renew your skin in a gradual and long-lasting way by stimulating collagen production.6 Sculptra® gives you control of your skin and the power to look as great as you feel.
TREATMENT AREAS
Sculptra® volume and firmness to areas of your face that have become loose and saggy.7 Examples include smile lines (also called nasolabial folds), laugh lines (or marionette lines) and chin wrinkles. The treatment helps gradually replace lost collagen and results may last for more than two years.8 Sculptra®will reinvigorate your skin and bring back your youthful appearance.
80% of users were still satisfied with their Sculptra® treatment 25 months after their last injection, according to a clinical study.9
Your Sculptra® treatment
Sculptra® is injected in the deep layers of your skin to stimulate its own collagen production.10 You will gradually notice visible improvements of skin firmness and fullness, and results can last for more than two years.11 On average, three treatment sessions are needed over a few months.
Immediately after each treatment session, you may experience some swelling that will temporarily reduce wrinkles and folds. Thereafter, the gradual process of collagen replacement starts. Sculptra® works subtly, improving facial areas gradually to give you a youthful and natural-looking result that lasts.
How it works
The active ingredient in Sculptra® is poly-L-Lactic acid, PLLA. PLLA is a biodegradable substance that has been used for decades in dissolvable stitches for wound management. When PLLA is injected in the deeper layers of your skin, it helps stimulate your skin’s own natural collagen production.12 Thereby, your skin’s inner structure is improved and you will regain skin volume that has been lost to aging.13
80% rated Sculptra® as good to excellent after 25 months14
100% of patients would recommend Sculptra® to a friend15
Proven aesthetic results since 199916
FREQUENTLY ASKED QUESTIONS
Who distributes Sculptra?
Sculptra is distributed by Galderma. Galderma is a pharmaceutical company with over 6,000 employees worldwide. The company specializes in dermatology and is present in more than 100 countries. To read more about Galderma visit About Galderma.
Are you looking for a clinic?
Skin insights
OUR PORTFOLIO OF PRODUCTS
Galderma has developed a diverse portfolio of products that work holistically together.
RELAX
Relax the tension of facial muscles associated with crow´s feet and frown lines to show how you truly feel inside.
REFINE
Refine your facial features by lifting and shaping contours, filling lines and wrinkles or creating natural volume.
REFRESH
Refresh your skin from within with a boost of deep hydration, for a refreshed and vibrant look that lasts.
REFERENCES
1 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
2 Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
3 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg
2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.;
Moyle GJ et al. HIV Med 2004;5(2):82–7.; Bohnert K et al. Plast Reconstr Surg
2019;127(4):1684–92
4 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
5 Fisher GJ et al. Arch Dermatol 2008;144(5):666–72.; Werschler WP et al. J Clin Aesthet Dermatol 2015;8(10 Suppl):S2–S7.
6 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
7 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
8 Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
9 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
10 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
11 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
12 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
13 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.; Chen HH et al. JAMA Facial Plast Surg 2015;17(1):39–43.
14 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
15 Mest DR and Humble G. Dermatol Surg 2006;32(11):1336–45.
16 Sculptra was developed and CE approved for aesthetic use in the European market in 1999.